Repaglinide (0.5 mg) + Voglibose (0.2 mg) is an anti-diabetic combination medicine. Repaglinide is part of the meglitinide class. It works by stimulating the pancreas to release more insulin, a hormone that helps control blood sugar levels by enabling cells to take in and use glucose efficiently.
